MEZO G[au] - Search Results

Year	Number of Results
1986	1
1988	1
1989	2
1990	2
1993	2
1994	2
1995	1
1996	2
1997	1
1998	3
1999	2
2000	4
2002	2
2003	6
2004	6
2005	4
2006	3
2007	3
2008	8
2009	9
2010	6
2011	8
2012	8
2013	7
2014	1
2015	6
2016	3
2017	5
2018	8
2019	9
2020	10
2021	5
2022	6
2023	5

1

NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review.

Trencsényi G, Enyedi KN, Mező G, Halmos G, Képes Z. Trencsényi G, et al. Among authors: mezo g. Int J Mol Sci. 2023 Aug 11;24(16):12675. doi: 10.3390/ijms241612675. Int J Mol Sci. 2023. PMID: 37628856 Free PMC article. Review.

2

Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System.

Szabó I, Yousef M, Soltész D, Bató C, Mező G, Bánóczi Z. Szabó I, et al. Among authors: mezo g. Pharmaceutics. 2022 Apr 21;14(5):907. doi: 10.3390/pharmaceutics14050907. Pharmaceutics. 2022. PMID: 35631493 Free PMC article. Review.

3

Luteinizing hormone-releasing hormone antagonists.

Mezo G, Manea M. Mezo G, et al. Expert Opin Ther Pat. 2009 Dec;19(12):1771-85. doi: 10.1517/13543770903410237. Expert Opin Ther Pat. 2009. PMID: 19939192 Review.

4

Energy-resolved HCD fragmentation of daunorubicin-peptide conjugates.

Al-Majidi M, Szabó D, Dókus L, Steckel A, Mező G, Schlosser G. Al-Majidi M, et al. Among authors: mezo g. J Mass Spectrom. 2020 Oct;55(10):e4641. doi: 10.1002/jms.4641. J Mass Spectrom. 2020. PMID: 32930447 No abstract available.

5

lGnRH-III -- a promising candidate for anticancer drug development.

Manea M, Mező G. Manea M, et al. Among authors: mezo g. Protein Pept Lett. 2013 Apr;20(4):439-49. Protein Pept Lett. 2013. PMID: 23016589 Review.

6

Receptor-mediated tumor targeting based on peptide hormones.

Mezo G, Manea M. Mezo G, et al. Expert Opin Drug Deliv. 2010 Jan;7(1):79-96. doi: 10.1517/17425240903418410. Expert Opin Drug Deliv. 2010. PMID: 19947889 Review.

7

On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Vrettos EI, Mező G, Tzakos AG. Vrettos EI, et al. Among authors: mezo g. Beilstein J Org Chem. 2018 Apr 26;14:930-954. doi: 10.3762/bjoc.14.80. eCollection 2018. Beilstein J Org Chem. 2018. PMID: 29765474 Free PMC article. Review.

8

NGR-peptide-drug conjugates with dual targeting properties.

Enyedi KN, Tóth S, Szakács G, Mező G. Enyedi KN, et al. Among authors: mezo g. PLoS One. 2017 Jun 2;12(6):e0178632. doi: 10.1371/journal.pone.0178632. eCollection 2017. PLoS One. 2017. PMID: 28575020 Free PMC article.

9

New derivatives of GnRH as potential anticancer therapeutic agents.

Mezo G, Manea M, Szabí I, Vincze B, Kovács M. Mezo G, et al. Curr Med Chem. 2008;15(23):2366-79. doi: 10.2174/092986708785909157. Curr Med Chem. 2008. PMID: 18855666 Review.

10

[Comparison of therapeutic peptides targeting pancreatic cancer].

Mezõ G, Dókus L, Schlosser G, Lajkó E, Szász Z, Ranđelović I, Biri-Kovács B, Tóvári J, Kõhidai L. Mezõ G, et al. Magy Onkol. 2019 Dec 9;63(4):301-308. Epub 2019 Oct 21. Magy Onkol. 2019. PMID: 31821385 Free article. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year